S&P 500
5,928.48
-0.2%
-11.98
DJI
42,369.37
-0.7%
-307.87
NASDAQ
$19,205.90
+0.3%
+$63.18
Bitcoin
108,757.00
+3.9%
+4,080.37
AAPL
$206.89
+0.0%
+$0.03
AMZN
$203.09
-0.5%
-$0.98
GOOG
$174.24
+5.4%
+$8.92
META
$644.08
+1.1%
+$6.98
MSFT
$456.62
-0.3%
-$1.55
NVDA
$135.46
+0.8%
+$1.08
TSLA
$344.80
+0.3%
+$0.98
VolitionRx (NYSEMKT: VNRX)
$0.51
(3.9%)
$0.02
Price as of May 21, 2025, 11:14 a.m. ET
VolitionRx Return vs. S&P
| 1 Year | 5 Year | 5 Year Annualized | Since IPO |
|---|
VolitionRx Company Info
VolitionRX Ltd. engages in the development of blood-based cancer tests to help diagnose a range of cancers. Its products include the Nucleosomics platform that identifies and measures nucleosomes in the bloodstream or other bodily fluids. The company was founded on September 24, 1998 and is headquartered in Henderson, NV.
News & Analysis
No articles found.
Valuation
Earnings Transcripts
VolitionRX Ltd (VNRX) Q3 2021 Earnings Call Transcript
VNRX earnings call for the period ending September 30, 2021.
Motley Fool Transcribers | Nov 11, 2021
VolitionRX Ltd (VNRX) Q2 2021 Earnings Call Transcript
VNRX earnings call for the period ending June 30, 2021.
Motley Fool Transcribers | Aug 12, 2021
Volition Rx Limited (VNRX) Q1 2021 Earnings Call Transcript
VNRX earnings call for the period ending March 31, 2021.
Motley Fool Transcribers | May 12, 2021
Premium Investing Services
Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.